Literature DB >> 17727454

Pathogenesis of Helicobacter pylori infection.

Shin Maeda1, Andreas F Mentis.   

Abstract

The clinical outcome of Helicobacter pylori infection is determined by a complex interaction between the bacterium and the host. The main bacterial factors associated with pathogenicity comprise outer membrane proteins, including BabA, SabA, OipA, AlpA, and AlpB, the vacuolating cytotoxin VacA and the products of cagPAI. The multitude of putative virulence factors makes it extremely difficult to test the contribution of each individual factor. Much effort has been put into identifying the mechanism associated with H. pylori-associated carcinogenesis. Interaction between bacterial factors such as CagA and host signal transduction pathways seems to be critical for mediating cell transformation, cell proliferation, invasion, apoptosis/anti-apoptosis, and angiogenesis. An animal model using the Mongolian gerbil is a useful model for showing gastric pathology due to H. pylori infection which is similar to that in humans and can be used to evaluate virulence factors including CagA, host responses, and environmental factors such as salt intake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727454     DOI: 10.1111/j.1523-5378.2007.00529.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  22 in total

Review 1.  Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer.

Authors:  Mo-Ye Chen; Cai-Yun He; Xue Meng; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

2.  Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.

Authors:  Kosuke Sakitani; Yoshihiro Hirata; Yoku Hayakawa; Takako Serizawa; Wachiko Nakata; Ryota Takahashi; Hiroto Kinoshita; Kei Sakamoto; Hayato Nakagawa; Masao Akanuma; Haruhiko Yoshida; Shin Maeda; Kazuhiko Koike
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

3.  Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.

Authors:  Fen Wang; Li-Dan Luo; Jian-Hua Pan; Li-Hua Huang; Hong-Wei Lv; Qin Guo; Can-Xia Xu; Shou-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 4.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

5.  Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif.

Authors:  Shunfu Xu; Chao Zhang; Yi Miao; Jianjiong Gao; Dong Xu
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

6.  Activation of the abundant nuclear factor poly(ADP-ribose) polymerase-1 by Helicobacter pylori.

Authors:  Carlos W Nossa; Prashant Jain; Batcha Tamilselvam; Vijay R Gupta; Lin-Feng Chen; Valérie Schreiber; Serge Desnoyers; Steven R Blanke
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

7.  Monochloramine impairs caspase-3 through thiol oxidation and Zn2+ release.

Authors:  Jonathan E Kohler; Jeff Mathew; Kaniza Tai; Amy L Blass; Edward Kelly; David I Soybel
Journal:  J Surg Res       Date:  2008-06-27       Impact factor: 2.192

Review 8.  Oral medications for central serous chorioretinopathy: a literature review.

Authors:  William Fusi-Rubiano; Habiba Saedon; Vijay Patel; Yit C Yang
Journal:  Eye (Lond)       Date:  2019-09-16       Impact factor: 3.775

9.  Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy.

Authors:  Antonio Marcelo Barbante Casella; Rodrigo Fabri Berbel; Gláucio Luciano Bressanim; Marcus Rudolph Malaguido; José Augusto Cardillo
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

Review 10.  Helicobacter pylori infection in developing countries: the burden for how long?

Authors:  Barik A Salih
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.